BioCentury
ARTICLE | Company News

ShangPharma, UCSF partner to accelerate research

July 21, 2017 12:26 AM UTC

Under a new partnership, ShangPharma Innovation Inc. (South San Francisco, Calif.) will fund preclinical research at the University of California San Francisco (San Francisco, Calif.) to validate drug targets and discover drug candidates, the university said. The partners declined to disclose financial terms.

ShangPharma's affiliated CRO Shanghai ChemPartner Co. Ltd. (Shanghai, China) will also provide CRO services during the partnership. Both are affiliated with ShangPharma Corp. (Shanghai, China)...